FRACTYL HEALTH INC (GUTS) Stock News
NASDAQ:GUTS - Nasdaq - US35168W1036 - Common Stock - Currency: USD
GUTS Latest News and Analysis
What's going on in today's pre-market session
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Fractyl Health Announces Increased Focus on Groundbreaking Revita® Weight Maintenance and Rejuva® Pancreatic Gene Therapy Programs with Potential to Deliver Key Clinical Milestones Across Multiple Studies in 2025
Prioritizing Revita’s clinical development on weight maintenance post-GLP-1 withdrawal in response to significant patient and physician demand in ongoing...
Fractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local Delivery of RJVA-001 Rejuva® Smart GLP-1™ Pancreatic Gene Therapy at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)
RJVA-001 was successfully delivered in large animal Yucatan pig models at low total viral dose Results confirm ability to directly target pancreas with...
Fractyl Health to Present New Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)
BURLINGTON, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on...
Fractyl Health to Participate in the Upcoming December Conferences
Fractyl Health to Participate in the Upcoming December Conferences
BURLINGTON, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on...
Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business Updates
Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business Updates
REMAIN-1 weight maintenance pivotal study enrollment progressing rapidly; mid-point data analysis expected in Q2 2025...
Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar from its Rejuva® RJVA-001 Single-Administration GLP-1 Pancreatic Gene Therapy Candidate at ObesityWeek® 2024
13-week follow-up represents the longest data to-date demonstrating durable efficacy of RJVA-001 on weight and blood sugar in the diet-induced obesity...
Fractyl Health Presented New Analysis from Pooled Data of Revita® Clinical Studies Demonstrating Durable Weight Loss Maintenance for One Year at ObesityWeek® 2024
Single Revita procedure led to sustained, clinically meaningful weight loss in majority of patients with Type 2 Diabetes REMAIN-1 weight maintenance...
Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024
Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024
BURLINGTON, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on...
Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024
Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024
Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024...
Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines Conference
Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines Conference
Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines Conference...
Fractyl Health to Participate in Upcoming September Investor Conferences
Fractyl Health to Participate in Upcoming September Investor Conferences
Fractyl Health to Participate in Upcoming September Investor Conferences...
GUTS Stock Earnings: Fractyl Health Beats EPS for Q2 2024
GUTS stock results show that Fractyl Health beat analyst estimates for earnings per share the second quarter of 2024.
GUTS Stock Earnings: Fractyl Health Beats EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Fractyl Health (NASDAQ:GUTS) just reported results for the second quarter of 20...
Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates
Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates
Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates...
Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024
Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024
Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024...
Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs
Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs...
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
Company will discuss recent corporate updates, including compelling preclinical data from Rejuva® pancreatic gene therapy platform, which was named top abstract at American Diabetes Association’s 84th Scientific Session
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day
Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day...
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates...